EQRXEQRx, Inc.

Nasdaq eqrx.com


$ 2.34 $ -0.05 (-2.09 %)    

Wednesday, 08-Nov-2023 15:59:55 EST
QQQ $ 433.04 $ 1.75 (0.41 %)
DIA $ 383.81 $ 1.49 (0.39 %)
SPY $ 510.06 $ 1.80 (0.35 %)
TLT $ 88.99 $ 0.74 (0.84 %)
GLD $ 216.18 $ -0.44 (-0.2 %)
$ 2.34
$ 2.38
$ 0.00 x 0
$ 0.00 x 0
$ 2.32 - $ 2.42
$ 1.58 - $ 5.55
16,554,640
na
1.13B
$ 0.83
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2023 09-30-2023 10-Q
2 08-08-2023 06-30-2023 10-Q
3 05-08-2023 03-31-2023 10-Q
4 02-23-2023 12-31-2022 10-K
5 11-10-2022 09-30-2022 10-Q
6 08-11-2022 06-30-2022 10-Q
7 05-13-2022 03-31-2022 10-Q
8 03-23-2022 12-31-2021 10-K
9 11-15-2021 09-30-2021 10-Q
10 08-16-2021 06-30-2021 10-Q
11 05-26-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Revolution Medicines, Inc. (NASDAQ:RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted canc...

 why-aarons-shares-are-trading-lower-by-over-9-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation ...

 revolution-medicines-to-acquire-eqrx-in-all-stock-transaction-to-gain-over-1b-in-additional-capital

Revolution Medicines Inc (NASDAQ: RVMD) has agreed to acquire EQRx Inc (NASDAQ: EQRX) in an all-stock transaction intended to a...

 caterpillar-oshkosh-audiocodes-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks traded lower, with the Nasdaq Composite falling around 70 points on Tuesday. Here are some big stocks recording gai...

Core News & Articles

Revolution Medicines, Inc. ("Revolution Medicines" or the "Company") (NASDAQ:RVMD), a clinical-stage oncology c...

 goldman-sachs-maintains-neutral-on-eqrx-lowers-price-target-to-3

Goldman Sachs analyst Chris Shibutani maintains EQRx (NASDAQ:EQRX) with a Neutral and lowers the price target from $5 to $3.

 eqrx-announces-massive-strategic-reset-slashes-pipeline--workforce

EQRx Inc (NASDAQ: EQRX) will lay off 170 people and incur non-recurring costs of approximately $45 - $55 million for wind down,...

 eqrx-q1-eps-017-misses-015-estimate

EQRx (NASDAQ:EQRX) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.15) by 13....

 earnings-scheduled-for-may-8-2023

Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 per share on revenue of $462....

 earnings-outlook-for-eqrx
Earnings Outlook For EQRx
05/05/2023 17:02:46

 stocks-that-hit-52-week-lows-on-friday

  Friday's session saw 104 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 345 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-friday

  On Friday, 469 companies hit new 52-week lows.

 stocks-that-hit-52-week-lows-on-thursday

  On Thursday, 175 stocks hit new 52-week lows.

 stocks-that-hit-52-week-lows-on-monday

  On Monday, 198 companies hit new 52-week lows.

 on-march-8-eqrxs-jami-rubin-notified-co-of-her-decision-to-step-down-as-chief-financial-officer-effective-march-31

- Filing

 eqrx-q4-eps-005-up-from-006-yoy

EQRx (NASDAQ:EQRX) reported quarterly losses of $(0.05) per share. This is a 16.67 percent increase over losses of $(0.06) per ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION